Dublin, July 03, 2026 (GLOBE NEWSWIRE) — The “Photodynamic Therapy Market (2nd Edition) by Target Indication, Therapeutic Area, and Key Geographical Regions – Trends and Forecast, Till 2035” has been added to ResearchAndMarkets.com’s offering.
The global photodynamic therapy (PDT) market is projected to grow from USD 749 million in 2023 to USD 1.53 billion by 2035, with a CAGR of 8.3% during this period, driven by increased demand for minimally invasive treatments.
Photodynamic Therapy Market: Growth and Trends
Photodynamic therapy, a light-activated treatment using photosensitizing agents, has evolved significantly since its inception in the early 20th century. This therapy is known for its minimal systemic toxicity compared to chemotherapy and radiotherapy. Continuous innovations in photosensitizer design and light-delivery systems have expanded PDT applications beyond oncology to include antimicrobial and dermatological conditions. Administering photosensitizers locally reduces adverse effects and enhances the targeting of cancerous tissues. PDT has shown efficacy in treating various skin disorders like actinic keratosis and acne.
Global industry stakeholders are investing in new photoimmunotherapies and PDTs for multiple diseases. Over 70 therapies are under clinical development, with several PDT therapies already approved. Companies are leveraging nanotechnology for next-generation photosensitizers, anticipating significant market growth due to technological advancements and clinical interest.
Growth Drivers: Strategic Enablers of Market Expansion
Cancer and dermatological disorders’ rising prevalence is fueling the PDT market. PDT’s advantage in precise tumor ablation and minimized systemic toxicity makes it a sought-after treatment. Advancements in photosensitizer formulations and light-delivery technologies, like enhanced diode lasers, have improved PDT’s efficacy. Regulatory approvals and favorable reimbursements have boosted market adoption, especially in antimicrobial and age-related macular degeneration (AMD) treatments.
Market Challenges: Critical Barriers Impeding Progress
Challenges include limited tissue penetration, post-treatment photosensitivity, and high costs associated with advanced systems. Accessibility issues are evident in emerging markets. The need for specialized infrastructure and awareness hampers adoption, while stringent regulations and competition from alternate therapies add constraints.
Photodynamic Therapy Market Segmentation
By Target Indication:
- Actinic Keratosis
- Prostate Cancer
- Age-related Macular Degeneration
- Head and Neck Squamous Cell Carcinoma
- Basal Cell Carcinoma
By Therapeutic Area:
- Oncological Disorders
- Dermatological Disorders
- Ophthalmic Disorders
By Key Geographical Regions:
- North America
- Europe
- Asia-Pacific
- Middle East and North Africa
Key Segment Insights
The oncological disorders segment is expected to hold the largest market share at approximately 50%, with a CAGR of 11%. Actinic keratosis dominates the market due to its prevalence and PDT’s cosmetic effectiveness over traditional treatments. Meanwhile, the head and neck squamous cell carcinoma segment is anticipated to grow significantly due to promising combined PDT and immunotherapy approaches.
Regional Analysis
Europe: This region, holding nearly 50% of the market share, leads due to high non-melanoma skin cancer prevalence and robust healthcare systems offering support for PDT.
North America: Projected to grow at a 14% CAGR, driven by R&D investments, technological innovations, and healthcare modernization initiatives encouraging advanced treatment adoption.
Research Coverage
- Market sizing and opportunity analysis across target indications, therapeutic areas, and regions
- Detailed market landscape assessment, including development stages and light types
- Comprehensive company profiles with developments and future outlooks
- Clinical trial and patent analysis
- Market impact analysis of growth factors, restraints, and opportunities
Key Questions Answered
- Who are the leading companies in the PDT market?
- Which regions dominate the market?
- What are the observed market trends?
- What factors influence market evolution?
- What challenges do developers face?
- What is the market’s current and future size?
- What is the market’s CAGR?
- How will opportunities be distributed across segments?
Reasons to Buy this Report
- Comprehensive market analysis with revenue projections
- Insights into market drivers, barriers, opportunities, and challenges
- Identification of future opportunities
- Understanding of customer demand and tailoring strategies accordingly
- Guidance for new entrants’ market strategies
- Facilitated communication and business relation building
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 183 |
| Forecast Period | 2026 – 2035 |
| Estimated Market Value (USD) in 2026 | $749 Million |
| Forecasted Market Value (USD) by 2035 | $1530 Million |
| Compound Annual Growth Rate | 8.3% |
| Regions Covered | Global |
A selection of companies mentioned in this report includes, but is not limited to:
- ADVANZ PHARMA
- Biofrontera
- Biolitec Pharma
- Galderma
- Luzitin
- Nanospectra Biosciences
- Novartis
- Rakuten Medical
- Impact Biotech
- Theralase
For more information about this report visit https://www.researchandmarkets.com/r/sn7sa2
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Photodynamic Therapy Market
